Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Buy
57
FNB Quote, Financials, Valuation and Earnings
Last price:
$13.65
Seasonality move
:
-2.7%
Day range:
$13.23 - $13.66
52-week range:
$12.49 - $17.70
Dividend yield:
3.52%
P/E ratio:
10.83x
P/S ratio:
3.10x
P/B ratio:
0.78x
Volume:
1.9M
Avg. volume:
2.5M
1-year change:
0.15%
Market cap:
$4.9B
Revenue:
$1.6B
EPS (TTM):
$1.26
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | 1.82% | 0.32% | 16.65% | 8.87% | 1.59% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $439M | $450M | $462M | $540M | $566M | |
| Other Inc / (Exp) | $39M | $37M | $35M | -$40M | -$10M | |
| Operating Expenses | $435M | $460M | $462M | $540M | $566M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $343M | $503M | $553M | $584M | $555M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $57M | $98M | $114M | $99M | $90M | |
| Net Income to Company | $286M | $405M | $439M | $485M | $465M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $286M | $405M | $439M | $485M | $465M | |
| Basic EPS (Cont. Ops) | $0.86 | $1.24 | $1.23 | $1.32 | $1.27 | |
| Diluted EPS (Cont. Ops) | $0.85 | $1.23 | $1.22 | $1.31 | $1.27 | |
| Weighted Average Basic Share | $323.4M | $319.8M | $350M | $360.7M | $361.4M | |
| Weighted Average Diluted Share | $325.5M | $323.5M | $354.1M | $362.9M | $362.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $551M | $601M | $718M | $1.2B | $1.5B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $551M | $601M | $718M | $1.2B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $315M | $303M | $415M | $338M | $373M | |
| Revenue Growth (YoY) | 5% | -3.81% | 36.96% | -18.55% | 10.36% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $126M | $112M | $113M | $156M | $142M | |
| Other Inc / (Exp) | $7M | $10M | $10M | -$60M | -$27M | |
| Operating Expenses | $116M | $114M | $113M | $156M | $142M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $85M | $123M | $176M | $59M | $102M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13M | $24M | $37M | $8M | -$8M | |
| Net Income to Company | $72M | $99M | $139M | $51M | $110M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $72M | $99M | $139M | $51M | $110M | |
| Basic EPS (Cont. Ops) | $0.22 | $0.30 | $0.39 | $0.13 | $0.30 | |
| Diluted EPS (Cont. Ops) | $0.22 | $0.30 | $0.38 | $0.13 | $0.30 | |
| Weighted Average Basic Share | $322.5M | $319.1M | $353.3M | $361.2M | $361.5M | |
| Weighted Average Diluted Share | $324.9M | $323M | $357.9M | $362.3M | $362.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $121M | $144M | $249M | $266M | $349M | |
| Revenue (Reported) | $315M | $303M | $415M | $338M | $373M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $121M | $144M | $249M | $266M | $349M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $439M | $450M | $462M | $540M | $566M | |
| Other Inc / (Exp) | $39M | $37M | $35M | -$40M | -$10M | |
| Operating Expenses | $435M | $460M | $439M | $553M | $579M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $343M | $503M | $553M | $584M | $555M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $57M | $98M | $114M | $99M | $90M | |
| Net Income to Company | $286M | $405M | $439M | $485M | $465M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $286M | $405M | $439M | $485M | $465M | |
| Basic EPS (Cont. Ops) | $0.86 | $1.23 | $1.23 | $1.32 | $1.26 | |
| Diluted EPS (Cont. Ops) | $0.86 | $1.23 | $1.21 | $1.32 | $1.26 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $551M | $601M | $718M | $1.2B | $1.5B | |
| Revenue (Reported) | $1.2B | $1.2B | $1.4B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $551M | $601M | $718M | $1.2B | $1.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.4B | $1.6B | $1.6B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $450M | $462M | $540M | $566M | -- | |
| Other Inc / (Exp) | $37M | $35M | -$40M | -$10M | -- | |
| Operating Expenses | $460M | $439M | $553M | $579M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $503M | $553M | $584M | $555M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $98M | $114M | $99M | $90M | -- | |
| Net Income to Company | $405M | $439M | $485M | $465M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $405M | $439M | $485M | $465M | -- | |
| Basic EPS (Cont. Ops) | $1.23 | $1.23 | $1.32 | $1.26 | -- | |
| Diluted EPS (Cont. Ops) | $1.23 | $1.21 | $1.32 | $1.26 | -- | |
| Weighted Average Basic Share | $1.3B | $1.4B | $1.4B | $1.4B | -- | |
| Weighted Average Diluted Share | $1.3B | $1.4B | $1.5B | $1.5B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $601M | $718M | $1.2B | $1.5B | -- | |
| Revenue (Reported) | $1.2B | $1.4B | $1.6B | $1.6B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $601M | $718M | $1.2B | $1.5B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Short Term Investments | $3.5B | $3.4B | $3.3B | $3.3B | $3B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $5.3B | $7.4B | $5.5B | $5.4B | $6.1B | |
| Property Plant And Equipment | $332M | $345M | $432M | $461M | $536M | |
| Long-Term Investments | $6.3B | $6.9B | $7.4B | $7.2B | $7.4B | |
| Goodwill | $2.3B | $2.3B | $2.5B | $2.5B | $2.5B | |
| Other Intangibles | $54M | $42M | $89M | $69M | $51M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.3B | $1B | $930M | $1.9B | $585M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.4B | $1.2B | $2.4B | $1.1B | |
| Long-Term Debt | $1.2B | $812M | $1.2B | $2.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $32.4B | $34.4B | $38.1B | $40.1B | $42.3B | |
| Common Stock | $110M | $110M | $111M | $111M | $4M | |
| Other Common Equity Adj | -$39M | -$62M | -$357M | -$235M | -$169M | |
| Common Equity | $4.9B | $5B | $5.5B | $5.9B | $6.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5B | $5.2B | $5.7B | $6.1B | $6.3B | |
| Total Liabilities and Equity | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Cash and Short Terms | $4.8B | $6.9B | $4.9B | $4.8B | $5.4B | |
| Total Debt | $2.5B | $1.8B | $2.1B | $4B | $3.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Short Term Investments | $3.5B | $3.4B | $3.3B | $3.3B | $3B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $5.3B | $7.4B | $5.5B | $5.4B | $6.1B | |
| Property Plant And Equipment | $332M | $345M | $432M | $461M | $536M | |
| Long-Term Investments | $6.3B | $6.9B | $7.4B | $7.2B | $7.4B | |
| Goodwill | $2.3B | $2.3B | $2.5B | $2.5B | $2.5B | |
| Other Intangibles | $54M | $42M | $89M | $69M | $51M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.3B | $1B | $930M | $1.9B | $585M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.4B | $1.2B | $2.4B | $1.1B | |
| Long-Term Debt | $1.2B | $812M | $1.2B | $2.1B | $3.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $32.4B | $34.4B | $38.1B | $40.1B | $42.3B | |
| Common Stock | $110M | $110M | $111M | $111M | $4M | |
| Other Common Equity Adj | -$39M | -$62M | -$357M | -$235M | -$169M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5B | $5.2B | $5.7B | $6.1B | $6.3B | |
| Total Liabilities and Equity | $37.4B | $39.5B | $43.7B | $46.2B | $48.6B | |
| Cash and Short Terms | $4.8B | $6.9B | $4.9B | $4.8B | $5.4B | |
| Total Debt | $2.5B | $1.8B | $2.1B | $4B | $3.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286M | $405M | $439M | $485M | $465M | |
| Depreciation & Amoritzation | -$3M | $10M | $73M | $78M | $67M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $19M | $14M | -$42M | -$34M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $113M | $530M | $1.2B | $423M | $642M | |
| Capital Expenditures | $41M | $58M | $95M | $88M | $139M | |
| Cash Acquisitions | -- | -- | $188M | -- | -- | |
| Cash From Investing | -$1.8B | -$153M | -$3.1B | -$2.3B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$164M | -$179M | -$182M | -$177M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $328M | $25M | $381M | $1.2B | $1.4B | |
| Long-Term Debt Repaid | -$574M | -$438M | -$231M | -$352M | -$341M | |
| Repurchase of Common Stock | -$38M | -$43M | -$43M | -$36M | -$114M | |
| Other Financing Activities | $17M | $16M | $11M | $8M | $12M | |
| Cash From Financing | $2.5B | $1.7B | $18M | $1.7B | $1.9B | |
| Beginning Cash (CF) | $599M | $1.4B | $3.5B | $1.7B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $784M | $2.1B | -$1.8B | -$98M | $843M | |
| Ending Cash (CF) | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Levered Free Cash Flow | $72M | $472M | $1.1B | $335M | $503M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $72M | $99M | $139M | $51M | $110M | |
| Depreciation & Amoritzation | -$8M | $11M | $19M | $17M | $18M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $1M | -- | -$23M | -$2M | $2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $194M | $146M | $177M | -$20M | $326M | |
| Capital Expenditures | $8M | $15M | $17M | $17M | $48M | |
| Cash Acquisitions | -- | -- | $113M | -- | -- | |
| Cash From Investing | $452M | -$777M | -$642M | -$537M | -$470M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$41M | -$44M | -$46M | -$44M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6M | $7M | $14M | $4M | $502M | |
| Long-Term Debt Repaid | -$308M | -$211M | -$8M | -$1M | -$6M | |
| Repurchase of Common Stock | -$13M | -- | -- | $1M | -- | |
| Other Financing Activities | $3M | $4M | $4M | $3M | $2M | |
| Cash From Financing | -$163M | $14M | -$137M | $496M | $485M | |
| Beginning Cash (CF) | $900M | $4.1B | $2.3B | $1.6B | $2.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $483M | -$617M | -$602M | -$61M | $341M | |
| Ending Cash (CF) | $1.4B | $3.5B | $1.7B | $1.6B | $2.4B | |
| Levered Free Cash Flow | $186M | $131M | $160M | -$37M | $278M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $286M | $405M | $439M | $485M | $465M | |
| Depreciation & Amoritzation | -$3M | $10M | $73M | $78M | $67M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $19M | $14M | -$42M | -$34M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $113M | $530M | $1.2B | $423M | $642M | |
| Capital Expenditures | $41M | $58M | $95M | $88M | $139M | |
| Cash Acquisitions | -- | -- | $188M | -- | -- | |
| Cash From Investing | -$1.8B | -$153M | -$3.1B | -$2.3B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$165M | -$164M | -$179M | -$182M | -$177M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $328M | $25M | $381M | $1.2B | $1.4B | |
| Long-Term Debt Repaid | -$574M | -$438M | -$231M | -$352M | -$341M | |
| Repurchase of Common Stock | -$38M | -$43M | -$43M | -$36M | -$114M | |
| Other Financing Activities | $17M | $16M | $11M | $8M | $12M | |
| Cash From Financing | $2.5B | $1.7B | $18M | $1.7B | $1.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $784M | $2.1B | -$1.8B | -$98M | $843M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $72M | $472M | $1.1B | $335M | $503M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $405M | $439M | $485M | $465M | -- | |
| Depreciation & Amoritzation | $10M | $73M | $78M | $67M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $14M | -$42M | -$34M | -$4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $530M | $1.2B | $423M | $642M | -- | |
| Capital Expenditures | $58M | $95M | $88M | $139M | -- | |
| Cash Acquisitions | -- | $188M | -- | -- | -- | |
| Cash From Investing | -$153M | -$3.1B | -$2.3B | -$1.7B | -- | |
| Dividends Paid (Ex Special Dividend) | -$164M | -$179M | -$182M | -$177M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $25M | $381M | $1.2B | $1.4B | -- | |
| Long-Term Debt Repaid | -$438M | -$231M | -$352M | -$341M | -- | |
| Repurchase of Common Stock | -$43M | -$43M | -$36M | -$114M | -- | |
| Other Financing Activities | $16M | $11M | $8M | $12M | -- | |
| Cash From Financing | $1.7B | $18M | $1.7B | $1.9B | -- | |
| Beginning Cash (CF) | $11.1B | $11.7B | $6.7B | $7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1B | -$1.8B | -$98M | $843M | -- | |
| Ending Cash (CF) | $13.2B | $9.8B | $6.6B | $7.9B | -- | |
| Levered Free Cash Flow | $472M | $1.1B | $335M | $503M | -- | |
Get FNB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FNB
Sector
P/E ratio
10.83x
11.38x
PEG ratio
--
0.38x
P/B ratio
0.78x
1.07x
Price / LTM sales
3.10x
2.49x
Growth Metrics
FNB
Sector
Revenue growth
10.36%
6.9%
Earnings growth
130.77%
7.04%
Revenue (5-year growth)
5.68%
5.19%
Earnings forecast
$0.30
$0.57
Profitability
FNB
Sector
Profitability FY 2025
--
$159.4M
Return on invested capital
4.58%
5.5%
Return on assets
0.98%
0.99%
Return on equity
7.57%
9.5%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Apr
16
Estimated Next Earnings Date
Apr
23
Balance Sheet
FNB
Sector
Total cash
$5.4B
$470.2M
Short term investments
$3B
$259.5M
Total assets
$48.6B
$4.4B
Long term debt
$3.7B
$340.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
54
NUTX alert for Apr 3
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
52
PVH alert for Apr 3
PVH [PVH] is up 1.81% over the past day.
Sell
15
PCVX alert for Apr 3
Vaxcyte [PCVX] is up 4.47% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
